Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

New compounds show promise as nonsteroidal treatments for hair loss.

Blocking the KATP channel may help treat migraines.

Upadacitinib may effectively treat alopecia areata without side effects.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Dutasteride may help prevent prostate cancer, but more research is needed.

A new compound effectively inhibits human 5α-reductase 1.

Three compounds from Dadap leaves may help treat hair loss.

ATP-sensitive potassium channels play a role in chloroquine-induced itch in mice.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

Nerve signals are crucial for hair follicle stem cells to become skin stem cells and help in wound healing.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Promising cancer treatments were found, but the manufacturer closed.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.